Quest Diagnostics Inc (DGX) Free cash flow 2016–2025
Quest Diagnostics Inc (DGX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.4BFY2025 · since FY2016: $823.0M → $1.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.4B | +49.5% |
| FY2024 | $909.0M | +5.2% |
| FY2023 | $864.0M | -34.2% |
| FY2022 | $1.3B | -28.2% |
| FY2021 | $1.8B | +15.3% |
| FY2020 | $1.6B | +88.3% |
| FY2019 | $843.0M | +3.2% |
| FY2018 | $817.0M | -11.5% |
| FY2017 | $923.0M | +12.2% |
| FY2016 | $823.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice